← Back to Clinical Trials
Recruiting NCT06800547

NCT06800547 Latissimus Dorsi Flap Reconstructions: Retrospective Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06800547
Status Recruiting
Phase
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition Surgery
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2023-06-21
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2023-06-21 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Various options for reconstruction alternatives to LD are described, as are the possible early and late side effects of LD harvesting. Currently, the choice of whether or not to resort to LD harvesting to repair the defect is based on the experience and preference of the specific working group. The importance of the study lies in the attempt to analyze the choices made in the diagnostic and therapeutic phase (demolitive and reconstructive) on patients in order to correlate the outcomes obtained in terms of healing, quality of life and complications in the recipient site and in the donor site.

Eligibility Criteria

Inclusion Criteria: * Duration of surgery, expressed in minutes; * Hospitalization time, expressed in days; * Need for reoperation within 30 days of the first operation; * Survival and recurrences, based on the last available follow-up Exclusion Criteria: * Incomplete or missing data

Contact & Investigator

Central Contact

Marco Pignatti, MD

✉ marco.pignatti@unibo.it

📞 +390512143614

Principal Investigator

Marco Pignatti, MD

PRINCIPAL INVESTIGATOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Frequently Asked Questions

Who can join the NCT06800547 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06800547 currently recruiting?

Yes, NCT06800547 is actively recruiting participants. Contact the research team at marco.pignatti@unibo.it for enrollment information.

Where is the NCT06800547 trial being conducted?

This trial is being conducted at Bologna, Italy.

Who is sponsoring the NCT06800547 clinical trial?

NCT06800547 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Marco Pignatti, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology